PMID: 11903421Mar 21, 2002Paper

Treatment of high-risk diabetic patients with angiotensin II receptor blockers

Diabetes, Obesity & Metabolism
R Estacio

Abstract

In the United States, approximately 16 million people have diabetes; 90-95% have type 2 diabetes. They are at increased risk of developing hypertension and cardiovascular disease (CVD). The benefits of treating hypertension in diabetic patients and the potential to delay complications and reduce mortality have been demonstrated in clinical trials. Increasing evidence shows that angiotensin-converting enzyme (ACE) inhibitors and angiotensin II (Ang II) receptor blockers (ARBs) may be equally effective in delaying progressive renal disease in diabetic patients. Large, multicentre trials are ongoing to confirm the efficacy and superior safety profile of ARBs in this population.

References

Feb 9, 1984·The New England Journal of Medicine·C E Mogensen
Aug 1, 1995·Journal of Cardiovascular Pharmacology·D J CampbellA J Valentijn
Jun 1, 1993·Japanese Journal of Pharmacology·H OkunishiM Miyazaki
Jul 1, 1993·Journal of the American Society of Nephrology : JASN·A RemuzziG Remuzzi
Sep 23, 1996·Archives of Internal Medicine·M Epstein, G Bakris
Dec 1, 1996·American Journal of Hypertension·G L Bakris, M R Weir
May 7, 1997·JAMA : the Journal of the American Medical Association·J M Hoeg
Jul 3, 1998·Diabetes Research and Clinical Practice·H H Parving
Jul 29, 1998·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·H ButerD de Zeeuw
Jul 9, 1999·Diabetes/metabolism Research and Reviews·A R Mire-SluisA Lernmark
Jul 27, 1999·EDTNA/ERCA Journal : Official Journal of the European Dialysis and Transplant Nurses Association, European Renal Care Association·A L de Francisco
Jun 1, 1997·Journal of Internal Medicine·V LundbergF Huhtasaari
May 3, 2000·Kidney International·M W Taal, B M Brenner
Feb 28, 2001·Diabetes, Obesity & Metabolism·M R BurgeD S Schade

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.